11/26/2019 | 09/10/2019 | Lohxa LLC | Division of Pharmaceutical Quality Operations I | CGMP/Finished Pharmaceuticals/Adulterated |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, December 3, 2019
11/26/2019 | 11/18/2019 | EPH Technologies, Inc. | Center for Drug Evaluation and Research | CDER | Unapproved New Drugs/Misbranded |
Friday, November 29, 2019
16 hours ago - For example, if compounding with bulk substances pursuant to patient-specific prescriptions for nonfood-producing animals, FDA is stating that the drug should be compounded in accordance with applicable United States Pharmacope
Subscribe to:
Posts (Atom)